4 Active stocks to watch today 📈

Biotech is leading today's premarket gainers. Get a full report on all 4 top stocks inside [Image](www.elitetrade.club) Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. It's Thursday, November 3rd. Let's get ready to trade! Markets 📈 Stocks soldoff in yesterday's session following hawkish comments from Federal Reserve Chairman Jerome Powell. The S&P 500 lost 2.5% and the Dow slid 1.5%. The Nasdaq and Russell 2K both plummeted 3.3%. Today, futures are down in early-morning trading. S&P 500 contracts are down 0.5%. Sponsored [Get Your Money Out of U.S. Banks Immediately]( A historic financial reset in 2023 could soon result in a run on the banks. Get out of cash and into a new vehicle 50 years in the making. [MORE HERE]( Premarket Highlights 🔎 - Powell Chills Markets: Yesterday, Fed Chair Jay Powell said it's too early to predict when rate hikes will end, and added that rates will most likely have to go higher than was originally expected to tame inflation. . What to Watch Today 👀 Reality Check The market notched gains in October as investors were hopeful that the Fed would throttle back its rate hikes over the next few months, but I've been warning you for weeks that it was all wishful thinking. Yesterday, reality hit the market when Powell said rates would probably go much higher than expected and warned that rate hikes will not end anytime soon. Now, we're going to see the market throw a fit, and I wouldn't be surprised if we saw losses over the next few weeks. Just remember, until inflation cools off, rate hikes are likely to continue. International 🌍 Asia The Hang Seng Composite posted a dramatic 3.0% drop in Hong Kong, while Australia's ASX 200 lost 1.8% in a down day for Asian markets. Europe Germany's DAX is showing a 1.1% loss midway through its trading session, and the French CAC 40 is down 0.8%. The Euro Stoxx 600 is carrying a 1.1% decline. Major Earnings 💰 Conocophillips [COP] ... AM Cigna Corporation [CI] ... AM Regeneron Pharmaceuticals, Inc. [REGN] ... AM Zoetis Inc.[ZTS] ... AM Moderna, Inc. [MRNA] ... AM Air Products And Chemicals, Inc. [APD] ... AM Amgen Inc. [AMGN] ... PM Starbucks Corporation [SBUX] ... PM Paypal Holdings, Inc. [PYPL] ... PM Eog Resources, Inc. [EOG] ... PM Economy 🏗 - Jobless claims [Oct] ... 8:30a - Foreign trade deficit [Sep] ... 8:30a - Productivity (SAAR) [Q3] ... 8:30a - Unit labor costs (SAAR) [Q3] ... 8:30a - S&P U.S. services PMI (final) [Oct] ... 9:45a - ISM services index [Oct] ... 10a - Factory orders Sep] ... 10a Running Hot 🔥 Gainers - COMSovereign Holdings [COMS] >> +28.7% - Biophytis [BPTS] >> +35.5% - Viking Therapeutics [VKTX] >> +20.7% Decliners - Aurinia Pharma [AUPH] >> (32.3%) - Roku [ROKU] >> (19.3%) - Peloton [PTON] >> (17.8%) Etsy, Inc [ETSY] - Last Close: $87.54 Upbeat earnings results are lifting shares of ETSY. The eCommerce stock reported its Q3 earnings results on Tuesday evening, and the numbers surpassed analysts' expectations. Etsy generated a diluted net loss of $7.62 after incurring an $8.20 impairment charge, but revenues of $594.5 million beat the Street's $564.2 million target by a wide margin. The company also reported that its new buyer additions are 'well-above' pre-pandemic averages after its upbeat Q3. ETSY is one of today's top S&P 500 stocks with a 9.5% gain. My Take: ETSY is starting to look like a decent deal. It has support at the $70 mark, and its P/E ratio is a surprisingly digestible 31.36. This could be a promising swing trade if ETSY can get its groove back. Virax Biolabs Group Ltd [VRAX] - Last Close: $1.68 Virax Biolabs is moving higher on a premarket announcement. Today, the London-based biotech introduced the public to its new RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit. The testing kits have been launched in markets accepting the CE mark, like the EU. Test kits can be used both at-home and in point-of-care, and it produces results in about 15 minutes. Shares of VRAX are up 22.6% on the heels of the new product launch. My Take: This UK-based biotech stock has been up-trending for a week or so, but expect volatility if you plan to dabble in this one. Starry Group Holdings [STRY] - Last Close: $0.28 Starry Group is running hot after it mad a key comment in its quarterly report. The wireless technology developer reported its Q3 results early Wednesday, and the release sparked a sharp rally. Starry Group's Q3 EPS came in at -$(0.37), slightly worse than the expectation of a -$(0.36) per share loss. Revenues of $8 million also disappointed analysts' $8.8 million target. However, Starry Group's admission that it had retained PJT Partners to explore potential mergers and acquisitions got investors' attention. STRY soared 55.5% on Wednesday in light of the stock's potential as a buyout target, and the rally continued into today's premarket. STRY is trading actively with a 17.8% gain ahead of today's opening bell. My Take: Buyout rumors seem to be driving this rally, but the potential upside must be greatly reduced after two days of sharp gains. The trade has paid off for early movers, but I'm afraid it's a little late in the game for newcomers. Aptose Biosciences Inc [APTO] - Last Close: $0.55 A strong quarterly report is giving Aptose Biosciences a premarket boost. The clinical-stage biotech firm reported a loss of C$(0.11) in Q3, beating the consensus target of a C$(0.12) per share loss. Aptose also said it had a cash runway that fund operations and R&D through the first quarter of 2024. The earnings release also included some promising clinical updates on HM43239, AKA tuspetinib. CEO William Rice said, the company is looking forward to "providing the full scope of blast reduction and response rate data from the Phase 1/2 trial in the ASH timeframe next month." APTO is up 18.1% on the upbeat earnings results. My Take: APTO's financial figures weren't particularly impressive, so I would guess that the update on tuspetinib is the primary driver of this rally. The market seems to think the drug has promise, but it's too early to know for sure if it will get a full approval. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( P.P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](